During the past decade, Hospital Italiano de Rosario conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Italiano de Rosario" are "Pulmonary Arterial Hypertension" (4 trials), "COVID-19" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Hospital Italiano de Rosario" in a lesser frequency.

Most popular intervention types in "Hospital Italiano de Rosario" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Androgen Deprivation Therapy (ADT)" (1 trials), "Apalutamide" (1 trials), "Apremilast" (1 trials) and "Apremilast placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Italiano de Rosario" are 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Italiano de Rosario". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital Italiano de Rosario, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Italiano de Rosario, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".